Blogs
Search results will be updated while typing.
Blog
Assessing the implications of Medicare drug price negotiations for drug development sponsors
16 September 2024
Blog
Natural history research is powering more effective decision-making in oncology clinical trials
11 August 2025
Blog
Future-Proofing SaMD: Regulatory Strategies for Medical Software Development
4 February 2025
Blog
Rapid diagnostic advantages in clinical research
20 January 2025
Blog
See how we navigated complexities in a Phase I ICU trial
21 January 2025
Blog
Highlighting Fortrea’s commitment to advancing rare disease clinical research
23 January 2025
Blog
Key challenges in pediatric vaccine trials in low- and middle- income countries
29 January 2025
Blog
Addressing challenges of data management for cosmetic, personal care and over-the-counter products
1 October 2024
Blog
Incorporating sustainability into our clinical research operations
23 September 2024
Blog
Advanced therapies: The advantage of early and frequent regulatory interactions
9 October 2024
Blog
NICE technology appraisals of oncology treatments
10 September 2024
Blog
How Fortrea helped enroll over 5,000 patients 30 days early
20 August 2024
Blog
Creating a combined advanced therapy medicinal product as an SME in the EU
12 August 2024
Blog
Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease
6 August 2024
Blog
Understanding the three types of Advanced Therapy Medicinal Products (ATMPs)
31 July 2024
Blog
The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union
11 July 2024
Blog
Clinical Development in the Precision Medicine Era
3 July 2024
Blog